Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese

scientific article published on 01 February 1994

Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.14.2.265
P698PubMed publication ID8305419

P2093author name stringH Kato
T Miyata
T Matsuo
T Sakata
K Kario
P433issue2
P304page(s)265-274
P577publication date1994-02-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleFluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese
P478volume14

Reverse relations

cites work (P2860)
Q44518845Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia
Q41823356Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor.
Q44045719Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese: Factor VII polymorphism and coronary disease
Q38757815Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.
Q72664696Factor VII hyperactivity and ischaemic heart disease
Q73165312Heparin lowers plasma levels of activated factor VII
Q43687646High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage
Q28360273Is activated factor VII associated with retinal vein occlusion?
Q50947214Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates
Q41047270Pathophysiology and inflammatory aspects of plaque rupture
Q73128607Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction
Q73378387Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
Q53815642Role of coagulation factor VII in pathogenesis of ischemic heart disease.
Q42832220The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol.
Q73353249[Coagulant activity of factor VII (FVIIc) in the elderly with ischemic heart disease]

Search more.